欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/0988/001
药品名称
Cabergolin "Teva"
活性成分
Cabergoline 0.5 mg
剂型
Tablet
上市许可持有人
Teva B.V. Swensweg 5 2031 GA Haarlem The Netherlands
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
France (FR)
Spain (ES)
许可日期
2007/07/29
最近更新日期
2024/09/23
药物ATC编码
N04BC06 cabergoline
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
cabergoline_dk_h_0988_001_pil_01_02_24
Date of last change:2024/09/23
Final Labelling
|
cabergoline_dk_h_0988_001_imp_01_02_24
Date of last change:2024/09/23
Final SPC
|
cabergoline_dk_h_0988_001_smpc_11_09_23
Date of last change:2024/09/06
Final Product Information
|
DKH0988001_003IB033 Cabergolin Teva 1_3_1 label_inner_0_5mg_eu clean
Date of last change:2024/09/06
Final Product Information
|
DKH0988001_003IB033 Cabergolin Teva 1_3_1 label_outer_0_5mg_eu clean
Date of last change:2024/09/06
Final Product Information
|
DKH0988001_003IB033 Cabergolin Teva 1_3_1 pil_0_5mg_eu clean
Date of last change:2024/09/06
Final Product Information
|
DKH0988001_003IB033 Cabergolin Teva 1_3_1 spc_0_5mg_eu clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase